Governance of Access

Responsible business practices give leading edge in Governance of Access

GSK and Takeda lead, followed closely by Novartis. All three demonstrate strong responsible business practices either by enforcing stringent compliance processes across their operations or by setting viable staff incentives.

1 GlaxoSmithKline plc
0 1 2 3 4 5
4.59

GlaxoSmithKline plc

Read more
1 Takeda Pharmaceutical Co. Ltd.
0 1 2 3 4 5
4.59

Takeda Pharmaceutical Co. Ltd.

Read more
2 Novartis AG
0 1 2 3 4 5
4.39

Novartis AG

Read more
3 AstraZeneca plc
0 1 2 3 4 5
4.32

AstraZeneca plc

Read more
4 Johnson & Johnson
0 1 2 3 4 5
4.25

Johnson & Johnson

Read more
5 Novo Nordisk A/S
0 1 2 3 4 5
4.12

Novo Nordisk A/S

Read more
5 Pfizer Inc.
0 1 2 3 4 5
4.12

Pfizer Inc.

Read more
6 Roche Holding AG
0 1 2 3 4 5
4.08

Roche Holding AG

Read more
7 Merck KGaA (Merck)
0 1 2 3 4 5
3.75

Merck KGaA (Merck)

Read more
8 Bayer AG
0 1 2 3 4 5
3.55

Bayer AG

Read more
8 Eisai Co. Ltd.
0 1 2 3 4 5
3.55

Eisai Co. Ltd.

Read more
9 Astellas Pharma Inc.
0 1 2 3 4 5
3.46

Astellas Pharma Inc.

Read more
10 Boehringer Ingelheim GmbH
0 1 2 3 4 5
3.28

Boehringer Ingelheim GmbH

Read more
11 Sanofi
0 1 2 3 4 5
3.05

Sanofi

Read more
12 Gilead Sciences Inc.
0 1 2 3 4 5
2.89

Gilead Sciences Inc.

Read more
13 Eli Lilly & Co.
0 1 2 3 4 5
2.85

Eli Lilly & Co.

Read more
14 Merck & Co., Inc. (MSD)
0 1 2 3 4 5
2.80

Merck & Co., Inc. (MSD)

Read more
15 Bristol Myers Squibb Co.
0 1 2 3 4 5
2.70

Bristol Myers Squibb Co.

Read more
16 Daiichi Sankyo Co. Ltd.
0 1 2 3 4 5
2.54

Daiichi Sankyo Co. Ltd.

Read more
17 AbbVie Inc.
0 1 2 3 4 5
2.52

AbbVie Inc.

Read more
0 1 2 3 4 5

The ranking above shows the position and score of each company in the 2021 Index. Click on a company's name to go to its full report card.

Get in touch

Back to top |